Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›OncLive® On Air›S17 Ep72: FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS

Science & Medicine

S17 Ep72: FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS

OncLive® On Air by Audioboom

Jul 31, 20267:11Science & Medicine

In today’s episode, we welcomed Douglas W. Sborov, MD, MS, to discuss the significance of the July 2026 FDA approval of isatuximab-irfc (Sarclisa Escena) for subcutaneous injection for multiple myeloma indications. Dr Sb...

Related Episodes

Continue listening to more episodes from OncLive® On Air.

S18 Ep33: Current Approaches and Future Directions for Early-Stage TNBC

Sep 4, 2026 - 28:35

Highlights from the PER® CME activity "Current Approaches and Future Directions for Early-Stage TNBC" — t...

S18 Ep32: Non–Small Cell Lung Cancer 2026 UPDATE

Aug 31, 2026 - 13:48

Two Onc Docs , hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to prov...

S18 Ep31: FDA Approval Insights: Integrating RP1 Plus Nivolumab Into Post–PD-1 Melanoma Practice: With Michael K. Wong, MD, PhD, FRPC

Aug 28, 2026 - 22:12

In today's episode, we spoke with Michael K. Wong, MD, PhD, FRPC. Dr Wong is a physician at Roswell Park...

S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD

Aug 28, 2026 - 27:52

Eric D. Whitman, MD, and Francis Paul Worden, MD, discuss the integration of immunotherapy into the cutan...

S18 Ep30: FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma: With Sagar Lonial, MD, FACP, FASCO

Aug 27, 2026 - 8:01

In today’s episode, we welcomed Sagar Lonial, MD, FACP, FASCO, to discuss the significance of the August...

S18 Ep29: 𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment

Aug 24, 2026 - 29:14

Highlights from the PER® CME activity " MET Alterations in NSCLC: Applying Diagnostic Advances and Target...

S18 Ep28: Pancreatic Cancer Treatment Advances Call for a Renewed Focus on the Role of Liposomal Irinotecan: With Jennifer B. Valerin, MD, PhD

Aug 20, 2026 - 17:02

In today’s episode, we spoke with Jennifer B. Valerin, MD, PhD. Dr Valerin is an assistant professor in t...

S18 Ep27: Key Considerations for Health Equity and Patient-Centered Care in TNBC

Aug 17, 2026 - 25:59

Highlights from the PER® CME activity "Key Considerations for Health Equity and Patient-Centered Care in...